v3.20.4
Fourth Quarter Financial Results (unaudited) (Tables)
12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Schedule of fourth quarter financial results
quarter ended December 31 (in millions except per share data)2020
Net revenues$13,858 
Gross margin9,174 
Net earnings attributable to AbbVie Inc.(a)
36 
Basic earnings per share attributable to AbbVie Inc.$0.01 
Diluted earnings per share attributable to AbbVie Inc.$0.01 
Cash dividends declared per common share$1.30 
(a)Fourth quarter results in 2020 included after-tax charges of $4.7 billion related to the change in fair value of contingent consideration liabilities partially offset by an after-tax benefit of $1.5 billion due to impacts related to tax law changes.